Merck Unit’s Plea Over Vioxx Investigation Accepted by Judge

A unit of Merck & Co., the second-largest U.S. drugmaker, pleaded guilty to a criminal misdemeanor charge as part of a $950 million settlement of a U.S. government probe of its illegal marketing of the painkiller Vioxx.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.